Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × Chalazion × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Completed 3 Unknown 2 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 602 Neoplasms 507 Prostatic Neoplasms 310 Lung Neoplasms 233 Colorectal Neoplasms 202 Motor Activity 130 Carcinoma, Non-Small-Cell Lung 114 Uterine Cervical Neoplasms 112 Head and Neck Neoplasms 109 Pancreatic Neoplasms 106 Brain Neoplasms 105 Rectal Neoplasms 101 Carcinoma, Hepatocellular 100 Stomach Neoplasms 97 Colonic Neoplasms 86 Ovarian Neoplasms 85 Esophageal Neoplasms 70 Neoplasm Metastasis 65 Multiple Myeloma 61 Urinary Bladder Neoplasms 60 Hematologic Neoplasms 60 Sarcoma 58 Melanoma 58 Glioblastoma 57 Endometrial Neoplasms 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Glioma 54 Lymphoma 53 Anxiety Disorders 52 Gastrointestinal Neoplasms 51

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡